Genetic Technologies (AU:GTG) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genetic Technologies Limited has announced an extension to the voluntary suspension of its securities as it finalizes funding agreements crucial for its Entitlement Offer and a strategic distribution partnership. This move comes as the company seeks to strengthen its financial standing and market presence in genomics-based health solutions. The suspension is expected to last until November 4, 2024, unless an earlier update is provided.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.